{
    "medicine_id": "3c6f48f3e9983523f5405e28e73634d6d7fe25a1",
    "platform_id": "DB04847",
    "metadata": {
        "name": "Ixempra 15 mg 15mg Kit",
        "composition": "15 mg 15mg Roxadustat",
        "clinical_particulars": {
            "therapeutic_indications": "In clinical development for the treatment of anemia of chronic inflammatory disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "FG 4592 represents one of several next generation PHI that has been optimized for multiple pharmacokinetic and pharmacodynamic parameters related to erythropoiesis including selective inhibition of HIF prolyl and asparaginyl hydroxylases potency iron utilization and ADME FG 4592 represents one of several next generation HIF PH inhibitors designed to selectively induce the expression of genes that mediate erythropoiesis for the treatment of anemia",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}